299 companies
SRNEQ
Sorrento Therapeutics, Inc.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases.
California
NASDAQ
ONCE
Spark Therapeutics Inc
We are a leader in the field of gene therapy, seeking to transform the lives of patients suffering from debilitating genetic diseases by developing potentially one-time, life-altering treatments.
Pennsylvania
NASDAQ
SWTX
SpringWorks Therapeutics Inc
springworks therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities.
Connecticut
NASDAQ
SURF
Surface Oncology, Inc.
surface oncology was created to advance next‐generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno‐biology.
Massachusetts
NASDAQ
SRZN
Surrozen Inc
surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the wnt signaling pathway.
California
NASDAQ
STRO
Sutro Biopharma Inc
at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics.
California
NASDAQ
TCBP
TC BioPharm (Holdings) plc
TC BioPharm (Holdings) plc (TCB) is a clinical-stage biopharmaceutical company with a cell-based product pipeline capable of treating a variety of disorders including cancer and infectious disease.
United Kingdom
NASDAQ
TCON
TRACON Pharmaceuticals Inc
tracon pharmaceuticals, inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (amd). its lead clinical stage products include envafolimab (kn035), an investigational pd-l1 single-domain antibody for the treatment of soft tissue sarcoma.
California
NASDAQ
TARS
Tarsus Pharmaceuticals Inc
tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions.
California
NASDAQ
TSHA
Taysha Gene Therapies Inc
taysha gene therapies, inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system.
Texas
NASDAQ
TCRR
Tcr2 Therapeutics Inc
TCR2 Therapeutics Inc.
Massachusetts
NASDAQ
TNYA
Tenaya Therapeutics Inc
tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group.
California
NASDAQ
TNGNQ
Tengion, Inc.
Tengion, Inc.
North Carolina
OTC
TVGN
Tevogen Bio Holdings Inc.
Semper Paratus Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
New York
NASDAQ
TTNP
Titan Pharmaceuticals, Inc. (de)
titan pharmaceuticals inc.
California
NASDAQ
TRML
Tourmaline Bio Inc
talaris therapeutics is a late-clinical stage biotechnology company based in boston, ma and louisville, ky.
New York
NASDAQ
Translate Bio, Inc.
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, or to prevent infectious diseases by generating protective immunity.
Massachusetts
TCRX
Tscan Therapeutics Inc
harnessing novel t cell systems to extend the promise of immunotherapy
Massachusetts
NASDAQ
TSBX
Turnstone Biologics Corp
Turnstone Biologics is a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy.
California
NASDAQ
TWST
Twist Bioscience Corp
at twist bioscience, our expertise is synthetic dna.
California
NASDAQ